Delivery Order SPE2DB20D1100-SPE2DB24FC0M6

Award Date 5/31/24
Potential Completion Date 6/24/24
Potential Value $8.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The award, valued at $7,339.50, is for the delivery of XEOMIN 200 unit vials, a pharmaceutical product. The contract has an ultimate completion date of August 1, 2024 and is a Firm Fixed Price Delivery Order. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The $2,850.00 Firm Fixed Price Delivery Order is for the supply of 4,564,520,191 units of the drug XEOMIN (50 unit vials) with a completion date of May 28, 2024. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,850.00 firm-fixed-price delivery order is for the supply of XEOMIN 50 unit vials. The contract has an ultimate completion date of October 10, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for...
This federal contract award, valued at $3,145.50, was issued by the Defense Logistics Agency (DLA) to the Amerisourcebergen Drug Corporation's Corporate Office Division. The award is a delivery order contract for the supply of XEOMIN 200 unit vials, a pharmaceutical product. Amerisourcebergen, a major pharmaceutical distribution company, holds an Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support Medical, which serves as the primary vehicle for the company...
This federal contract award, valued at $13,559.00, was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a delivery order for the provision of 4,566,773,316 units of the pharmaceutical product XEOMIN 200 UNIT VIALS. The contract has a firm fixed-price pricing type and an ultimate completion date of January 13, 2025. This award is part of a larger Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,097.00 firm fixed-price delivery order is for the delivery of 200-unit vials of the pharmaceutical product XEOMIN. The contract has a period of performance through March 6, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract, valued at up to $5,242.40, is for the delivery of XEOMIN 100 unit vials and has a completion date of July 2, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,420.50 firm-fixed-price delivery order is for the supply of 4,568,252,863 units of the medication XEOMIN 100 UNIT VIALS. The contract has an ultimate completion date of June 5, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office division is for the delivery of XEOMIN 100 unit vials. The $3,931.80 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency that provides logistics, acquisition, and technical services to the U.S. Armed Forces and other government entities. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the...
This federal contract award, valued at $5,242.50, was issued by the Medical Supply Chain division of the Department of Defense (Defense Logistics Agency Troop Support) to Amerisourcebergen Drug Corp's Corporate Office Division. The award is a Delivery Order for the supply of XEOMIN 200 unit vials, a pharmaceutical product. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency valued up to...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FC0M6
    Delivery Order

This federal contract award, valued at $8,550.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4564795627 units of the pharmaceutical product XEOMIN 50 UNIT VIALS. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a wide range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract awarded on May 31, 2024 does not have a set-aside designation and is a Firm Fixed Price Delivery Order. Amerisourcebergen also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.

Generated 8/30/24, 7:00 PM